umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Current Status and Future Prospects of Clinically Exploiting Cancer-specific Metabolism: Why Is Tumor Metabolism Not More Extensively Translated into Clinical Targets and Biomarkers?
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet).
Umeå universitet, Teknisk-naturvetenskapliga fakulteten, Institutionen för molekylärbiologi (Teknisk-naturvetenskaplig fakultet).ORCID-id: 0000-0003-3676-817X
2019 (engelsk)Inngår i: International Journal of Molecular Sciences, ISSN 1422-0067, E-ISSN 1422-0067, Vol. 20, nr 6, artikkel-id 1385Artikkel, forskningsoversikt (Fagfellevurdert) Published
Abstract [en]

Tumor cells exhibit a specialized metabolism supporting their superior ability for rapid proliferation, migration, and apoptotic evasion. It is reasonable to assume that the specific metabolic needs of the tumor cells can offer an array of therapeutic windows as pharmacological disturbance may derail the biochemical mechanisms necessary for maintaining the tumor characteristics, while being less important for normally proliferating cells. In addition, the specialized metabolism may leave a unique metabolic signature which could be used clinically for diagnostic or prognostic purposes. Quantitative global metabolic profiling (metabolomics) has evolved over the last two decades. However, despite the technology's present ability to measure 1000s of endogenous metabolites in various clinical or biological specimens, there are essentially no examples of metabolomics investigations being translated into actual utility in the cancer clinic. This review investigates the current efforts of using metabolomics as a tool for translation of tumor metabolism into the clinic and further seeks to outline paths for increasing the momentum of using tumor metabolism as a biomarker and drug target opportunity.

sted, utgiver, år, opplag, sider
MDPI, 2019. Vol. 20, nr 6, artikkel-id 1385
Emneord [en]
translational medicine, metabolomics, metabolism, cancer, tumor, biomarker, drug discovery, metabolic homeostasis
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-158594DOI: 10.3390/ijms20061385ISI: 000464326900019PubMedID: 30893889OAI: oai:DiVA.org:umu-158594DiVA, id: diva2:1318327
Tilgjengelig fra: 2019-05-27 Laget: 2019-05-27 Sist oppdatert: 2019-05-27bibliografisk kontrollert

Open Access i DiVA

fulltext(2139 kB)61 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 2139 kBChecksum SHA-512
404743cc50f26d42c47136b492234dc6e8cc5af6bec34e31066c5755236dbac5cacf114edd3742464dd270ced20445d06fd6849701e74f1a206c228391b28124
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Muthu, MageshNordström, Anders

Søk i DiVA

Av forfatter/redaktør
Muthu, MageshNordström, Anders
Av organisasjonen
I samme tidsskrift
International Journal of Molecular Sciences

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 61 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 127 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf